BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 70 filers reported holding BELLICUM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $116,000 | +93.3% | 68,155 | +281.2% | 0.01% | +133.3% |
| Q1 2019 | $60,000 | -23.1% | 17,878 | -33.1% | 0.00% | -25.0% |
| Q4 2018 | $78,000 | -67.2% | 26,722 | -30.9% | 0.00% | -73.3% |
| Q3 2018 | $238,000 | +205.1% | 38,673 | +266.8% | 0.02% | +400.0% |
| Q2 2018 | $78,000 | -86.6% | 10,542 | -84.7% | 0.00% | -90.3% |
| Q4 2017 | $581,000 | +71.4% | 69,039 | +135.2% | 0.03% | +82.4% |
| Q3 2017 | $339,000 | – | 29,358 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 15,086 | $306,000 | 0.84% |
| Baker Brothers Advisors | 4,865,647 | $98,627,000 | 0.82% |
| Cormorant Asset Management, LP | 300,000 | $6,081,000 | 0.73% |
| SPHERA FUNDS MANAGEMENT LTD. | 231,515 | $4,693,000 | 0.69% |
| QVT Financial LP | 340,986 | $6,912,000 | 0.39% |
| Graticule Asia Macro Advisors LLC | 87,000 | $1,763,000 | 0.29% |
| Hatteras Investment Partners, LP | 10,410 | $211,000 | 0.28% |
| MCDANIEL TERRY & CO | 33,836 | $686,000 | 0.18% |
| Highlander Capital Management, LLC | 6,500 | $132,000 | 0.12% |
| EverPoint Asset Management, LLC | 265,000 | $5,372,000 | 0.11% |